Erica Fiorini Jul 21 Zhejiang University Landmark Discovery by Erica Fiorini | July 21, 2025 147 Cancer immunotherapy has emerged as an effective strategy in oncology treatment. However, achieving localized, persistent immune stimulation at tumor sites while effectively counteracting the immunosu... Read more > Company Blog Jul 21, 2025 Company Blog
Erica Fiorini Jun 16 Turning CRISPR Challenges into Breakthroughs: How CellEDIT Empowered Cancer Research at the University of Navarra by Erica Fiorini | June 16, 2025 873 Today, we are pleased to introduce Dr. Alfonso Calvo , a principal investigator at Cancer Center Clínica Universidad de Navarra (CCUN) in Spain. His research focuses on understanding how changes in th... Read more > Company Blog Jun 16, 2025 Company Blog
Erica Fiorini Apr 09 Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer by Erica Fiorini | April 9, 2025 1962 New CCO Joins as Cytosurge Engages in Key Scientific Events Across the USA and Beyond Zurich, Switzerland – April 9, 2025 – Cytosurge AG, a leading biotech company in single-cell manipulation and cell... Read more > Press Release Apr 9, 2025 Press Release
Erica Fiorini Feb 05 Unlocking Spirostomum’s Secrets by Erica Fiorini | February 5, 2025 2463 Single-cell research has reached an exciting milestone with the successful biopsy of Spirostomum, a unique unicellular organism, using the FluidFM OMNIUM platform. This achievement demonstrates the ve... Read more > Company Blog FluidFM Applications Feb 5, 2025 Company Blog
Erica Fiorini Jan 20 Pushing New Frontiers in Malaria Research by Erica Fiorini | January 20, 2025 1262 In Rijswijk, the Netherlands, the Biomedical Primate Research Centre (BPRC) is making strides in infectious disease research. Recently, two of its scientists, Dr. Anne-Marie Zeeman and Dr. Annemarie M... Read more > Company Blog FluidFM Applications Jan 20, 2025 Company Blog
Erica Fiorini Jan 09 Cytosurge Announces Strategic Leadership Transition by Erica Fiorini | January 9, 2025 2860 Simon Egli Appointed Chief Executive Officer as Co-Founder Pascal Behr Transitions to Board of Directors Zürich, Switzerland – January 9, 2025 – Cytosurge AG, a leader in single-cell manipulation, a b... Read more > Press Release Jan 9, 2025 Press Release
Erica Fiorini Dec 17 Triple Hit From Peking University, China! by Erica Fiorini | December 17, 2024 2971 Recently, Peking University, Beijing, China, celebrated three major publications featuring FluidFM technology, listed below in chronological order: Quiescent cancer cells induced by high-density culti... Read more > Company Blog FluidFM Applications Dec 17, 2024 Company Blog
Erica Fiorini Dec 10 Insights from the FluidFM Conference 2024 by Erica Fiorini | December 10, 2024 3099 Exploring the Boundaries of Science with FluidFM The recent FluidFM Conference brought together a dynamic community of scientists, researchers, and innovators from around the world all eager to share ... Read more > Company Blog FluidFM Applications Dec 10, 2024 Company Blog
Erica Fiorini Oct 15 Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing by Erica Fiorini | October 15, 2024 3936 Collaboration to Enable Sequencing of Cells while Preserving Their Viability Zürich, Switzerland, and Vienna, Austria – October 15, 2024 – Cytosurge AG, a leader in single-cell manipulation, and Lex... Read more > Press Release Oct 15, 2024 Press Release
Erica Fiorini Jul 16 Streamlined U2OS Cell Line Modification with the CellEDIT Service Workflow by Erica Fiorini | July 16, 2024 8052 Today, we introduce you to Kanstantsin Siniuk, whose work focuses on mitochondrial metabolism as a target for developing treatments for mitochondrial and neurodegenerative diseases. Recently, Kanstant... Read more > Company Blog Jul 16, 2024 Company Blog
Erica Fiorini May 29 Cytosurge’s CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication by Erica Fiorini | May 29, 2024 5101 CellEDIT Service represents a novel workflow leveraging FluidFM-mediated intranuclear nanoinjection of CRISPR/Cas9 components into single cells. Control of the amount and stoichiometry of RNP complexe... Read more > Press Release Corporate FluidFM Applications May 29, 2024 Press Release
Ilaria Di Meglio Jul 20 Unlocking the secrets of cell adhesion by Ilaria Di Meglio | July 20, 2023 5604 Meet Dr Robert Horvath, head of the Nanobiosensorics Laboratory in Budapest, Hungary. Robert and his team are longstanding users of the FluidFM technology; they pioneered robotic FluidFM, which is now... Read more > Company Blog Jul 20, 2023 Company Blog
